phase readout
saveNCT05576896: Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory
TERMINATEDupdated 4d ago
community read0 votes
Sponsor: Northwestern University. Phase: PHASE2. Conditions: Stage IV Colorectal Cancer Positive for BRAF V600E Mutation, Colorectal Cancer, Colorectal Cancer Stage IV
view source ↗
comments(0)
5-min edit window · permanent after that